RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults

Clinical trial NCT02873286 · COMPLETED

Trial details

NCT number: NCT02873286
Sponsor: Bavarian Nordic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2016-09-01
Primary completion: 2018-12-01
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.